Viridian Therapeutics (VRDN) Held by Superinvestors
VIRIDIAN THERAPEUTICS INC (VRDN) is currently held by 1 superinvestors tracked by InsiderSet, with a combined reported market value of approximately $14.12M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Renaissance Technologies LLC is currently the largest disclosed institutional shareholder of VRDN tracked by InsiderSet, reporting ownership valued at approximately $14.12M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $19.45M, representing an estimated gain of +37.72% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed VRDN value among the investors covered in this analysis. Major shareholders include Renaissance Technologies LLC, and several other long-term asset managers with concentrated positions in VIRIDIAN THERAPEUTICS INC (VRDN).
This page ranks the largest institutional VRDN shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Jim Simons | 0.02% | 768,600 | $14,119,182 | $19,445,580 | +$5,326,398 | +37.72% |
Frequently asked questions about VRDN
Who are the largest superinvestors holding VRDN?
The largest superinvestors holding VRDN in the latest SEC Form 13F filings include Renaissance Technologies LLC. InsiderSet ranks these superinvestors by their latest reported VRDN position.
What does the VRDN superinvestors page include?
This page tracks VRDN positions reported by a curated group of notable institutional investors and fund managers through SEC Form 13F. VIRIDIAN THERAPEUTICS INC (VRDN) on this page reflects disclosed 13F holdings among those superinvestors, not every institutional shareholder of the stock.
How many superinvestors hold VRDN?
InsiderSet currently tracks 1 superinvestors reporting VRDN holdings in the latest available 13F data. This is the curated set on this page, not the total number of institutions that own VRDN.
How much VRDN stock do superinvestors hold?
Superinvestors tracked by InsiderSet disclosed approximately $14.12M in VRDN holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value, and it covers the curated superinvestors on this page rather than every institutional filer.
When were VRDN superinvestor holdings last updated?
The latest VRDN superinvestor holdings on InsiderSet are based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time holdings.
Are superinvestor VRDN holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by these superinvestors as of the end of the reporting quarter. A superinvestor may have changed its VRDN position after the reporting date.
Are superinvestors buying or selling VRDN?
Buying and selling can be analyzed by comparing VRDN positions across consecutive 13F reporting periods. InsiderSet's VRDN Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View VRDN ownership changes.
How have superinvestor VRDN holdings changed over time?
InsiderSet tracks VRDN holdings among these superinvestors across multiple 13F reporting periods, so holder counts, reported value, and reported shares can be compared over time.